Quantitative targeted proteomics for understanding the blood-brain barrier: Towards pharmacoproteomics

Sumio Ohtsuki, Mio Hirayama, Shingo Ito, Yasuo Uchida, Masanori Tachikawa, Tetsuya Terasaki

研究成果: Review article査読

33 被引用数 (Scopus)


The blood-brain barrier (BBB) is formed by brain capillary endothelial cells linked together via complex tight junctions, and serves to prevent entry of drugs into the brain. Multiple transporters are expressed at the BBB, where they control exchange of materials between the circulating blood and brain interstitial fluid, thereby supporting and protecting the CNS. An understanding of the BBB is necessary for efficient development of CNS-acting drugs and to identify potential drug targets for treatment of CNS diseases. Quantitative targeted proteomics can provide detailed information on protein expression levels at the BBB. The present review highlights the latest applications of quantitative targeted proteomics in BBB research, specifically to evaluate species and in vivo-in vitro differences, and to reconstruct in vivo transport activity. Such a BBB quantitative proteomics approach can be considered as pharmacoproteomics.

ジャーナルExpert Review of Proteomics
出版ステータスPublished - 2014 6月

ASJC Scopus subject areas

  • 生化学
  • 分子生物学


「Quantitative targeted proteomics for understanding the blood-brain barrier: Towards pharmacoproteomics」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。